Fishberg Department of Neuroscience and Friedman Brain Institute, New York, NY 10029.
Department of Neurosurgery, Icahn School of Medicine at Mount Sinai, New York, NY 10029.
eNeuro. 2018 Nov 20;5(6). doi: 10.1523/ENEURO.0219-18.2018. eCollection 2018 Nov-Dec.
Neural stem cells (NSCs) hold great promise for neural repair in cases of CNS injury and neurodegeneration; however, conventional cell-based transplant methods face the challenges of poor survival and inadequate neuronal differentiation. Here, we report an alternative, tissue-based transplantation strategy whereby cerebral organoids derived from human pluripotent stem cells (PSCs) were grafted into lesioned mouse cortex. Cerebral organoid transplants exhibited enhanced survival and robust vascularization from host brain as compared to transplants of dissociated neural progenitor cells (NPCs). Engrafted cerebral organoids harbored a large NSC pool and displayed multilineage neurodifferentiation at two and four weeks after grafting. Cerebral organoids therefore represent a promising alternative source to NSCs or fetal tissues for transplantation, as they contain a large set of neuroprogenitors and differentiated neurons in a structured organization. Engrafted cerebral organoids may also offer a unique experimental paradigm for modeling human neurodevelopment and CNS diseases in the context of vascularized cortical tissue.
神经干细胞(NSCs)在中枢神经系统损伤和神经退行性疾病的神经修复中具有巨大的应用潜力;然而,传统的基于细胞的移植方法面临着细胞存活率低和神经元分化不足的挑战。在这里,我们报告了一种替代的基于组织的移植策略,即将源自人类多能干细胞(PSCs)的脑类器官移植到损伤的小鼠皮层中。与分离的神经祖细胞(NPCs)移植相比,脑类器官移植显示出增强的存活和来自宿主大脑的强大血管生成。移植的脑类器官中含有大量的 NSC 池,并在移植后两周和四周显示出多谱系神经分化。因此,脑类器官作为 NSCs 或胎儿组织的一种有前途的替代移植来源,因为它们在一个结构化的组织中包含大量的神经祖细胞和分化的神经元。移植的脑类器官也可能为在血管化皮质组织背景下模拟人类神经发育和中枢神经系统疾病提供独特的实验范例。